NGL 2026 will bring clinicians, scientists, founders and investors together to turn healthspan ideas into clinical action.

Mission Therapeutics pairs brain-penetrant mitochondria drug with NeuraLight’s eye-tracking biomarkers in a multi-country ...

Phase 3 results presented in Munich and Barcelona show gains for two life-threatening conditions that quietly steal years ...

Deepinder Goyal’s brain-wearable startup Temple has acquired Longevous, pulling the cofounders into full-time roles steering ...

A new industry analysis maps 30-plus microbiome startups against longevity, and finds a field still torn between wellness and ...

Core Biogenesis and Faravelli are testing whether the biotech behind facial skincare can be scaled up to treat the rest of ...

Interviews: with scientists, founders, investors, clinicians, and pioneers experimenting on the frontiers of their own biology. Longevity.Technology is a registered ...

Sam Altman-backed Retro Biosciences is widening its Alzheimer’s trial after early doses showed no red flags. Most drug trials ...

New MOU pairs GlycanAge’s glycan-based biological age test with ExoEarth’s exosome platform, bringing inflammaging testing ...

Obesity biotech aims to reduce fat while preserving lean mass, with first-in-human studies planned for late 2027.

Six proteomic clocks detect a younger biological age signal in an IPF trial – but separating geroprotection from treatment ...

Leisure exercise lowers dementia risk, while physically demanding jobs may raise it – twist that reshapes how we think about ...